Introduction
Cell transformation by transcription factor v-Jun is assumed to take place through the activation or repression of a limited number of direct target genes. The characterization of these targets constitutes an important issue in order to decipher the oncogenic pathways downstream of this transcription factor. Direct targets are expected to contain a functional Jun-binding DNA element in their promoter and constitute a critical intermediate in cell transformation and tumorigenesis (Vogt et al., 1999; Vogt, 2001; van Dam and Castellazzi, 2001; Hartl et al., 2003) .
We have recently characterized several putative target genes repressed by v-Jun in chick embryo fibroblasts (CEFs) . A large proportion of them encode extracellular matrix components, among these, the SPARC (secreted protein, acidic, and rich in cysteine) and the alpha 2 (I) collagen genes (Vial and Castellazzi, 2000a) . Both proteins are highly conserved during evolution. SPARC is a minor, nonstructural component of the extracellular matrix that is thought, among other functions, to regulate tumor angiogenesis (Bradshaw and Sage, 2001; Chlenski et al., 2002) . a2 (I) Collagen assembles with a1 (I) collagen to form the type I collagen, which is the most abundant extracellular matrix protein in vertebrates (Trojanowska et al., 1998) . It is well documented that the transcription of both genes is repressed in avian and mammalian cultured cells transformed by various oncogenes (Schmidt et al., 1985; Slack et al., 1992; Mettouchi et al., 1994; Marhamati and Sonenshein, 1996; Oberst et al., 1999) , as well as in some human cancer cells (Brekken and Sage, 2000; Chlenski et al., 2002; Sengupta et al., 2003) . Their repression contributes to the oncogenic phenotype (Mok et al., 1996; Travers et al., 1996; Andreu et al., 1998; Du et al., 1999; Vial and Castellazzi, 2000a ).
An extensive analysis of the tata-less promoter of avian SPARC revealed that a short, proximal fragment, designated À124/ þ 16, is the target of repression by v-Jun (Vial et al., 2000b) . Surprisingly, v-Jun cannot bind this DNA fragment directly, but binds to a 5 0 -GGA repeat (À92/À57) indirectly, through the formation of DNA-Sp1/3-v-Jun chromatin-associated complex. In this promoter context, the ubiquitous site-specific transcription factors Sp1 and Sp3 are absolutely required for high, basal activity (presumably by recruiting the tata-binding complex; Pugh and Tjian, 1991; Black et al., 2001) , and consequently, for repression by v-Jun. Thus, a class of direct targets of v-Jun might exist whose transcription is modulated by an indirect binding of v-Jun to the relevant promoter, through a physical interaction with Sp1(-like) family members (Chamboredon et al., 2003) .
In the present work, we wondered whether the avian a2 (I) collagen gene constitutes a direct target of v-Jun, and if so, whether it obeys the mechanism of repression postulated for SPARC.
Results
Steady-state level of the a2 (I) collagen mRNA in v-Jun-transformed CEFs CEF cultures chronically infected by R, R-v-Jun, and Rv-Jun-m1 (a mutant of v-Jun that exhibits enhanced tumorigenicity in vivo; Huguier et al., 1998) were generated. Total RNA was subjected to Northern blot analysis with an avian radioactive probe of either a2 (I) collagen, SPARC, or glyceraldehyde 3-phosphate dehydrogenase gene (GAPDH) (Figure 1 ). The level of the collagen and SPARC mRNAs was estimated in the transformed CEFs in comparison to the nontransformed, R-infected CEFs (referred to as 100%; identical to noninfected, nontransformed CEFs; data not shown). A reduction of 50% and 70% was found in v-Juntransformed CEFs, with a2 (I) collagen and SPARC, respectively. An even stronger reduction was observed with v-Jun-m1 (over 90% in each case). Equal loading of the different lanes was verified after testing with a GAPDH probe. These data confirmed that transformation of CEFs by v-Jun(-m1) is accompanied by a reduction in the accumulation of the a2 (I) collagen and SPARC mRNAs (Vial and Castellazzi, 2000a) .
Characterization of a proximal fragment (À433/ þ 11) of the avian a2 (I) collagen promoter that responds to repression by v-Jun in CEFs
To investigate the mechanism of repression of the a2 (I) collagen gene by v-Jun, a large promoter fragment, extending from À1080 to þ 109 (Pallante et al., 1996) , was cloned in front of a luciferase reporter gene. Derivatives deleted for various 5 0 portions were also generated ( Figure 2 ). The transcriptional activity of the largest fragment À1080/ þ 109 was tested in transient transfection assays. As shown in Figure 3a , this large fragment dispayed a strong basal level of activity, arbitrarily set at 100%, in the absence of transfected Jun. In the presence of v-Jun or v-Jun-m1, its activity was reduced to 51 and 8%, respectively. A similar behavior was observed with the deleted forms À820/ þ 109 and À433/ þ 11. Interestingly, these data were reminiscent of the behavior of the short, proximal fragment (À124/ þ 16) of the avian SPARC promoter under the same experimental conditions (Figure 3b ; Vial et al., 2000b; Chamboredon et al., 2003) .
An even shorter promoter fragment, À237/ þ 11, exhibited a 50% reduced basal activity. Surprisingly, only v-Jun-m1, but no longer v-Jun, was capable of repressing the activity of this deleted form. This difference in behavior between the two oncoproteins could not be attributed to an enhanced accumulation of the mutated form as both proteins accumulated to the same extent in the transfected CEFs (data not shown; see Western blot data in Huguier et al., 1998; Vial et al., 2000b; Chamboredon et al., 2003) . Finally, the shortest Figure 1 Steady-state level of accumulation of the a2 (I) collagen, SPARC, and GAPDH mRNAs by Northern blot analysis with total RNA. Extracts were from CEFs chronically infected by the retroviruses R, R-v-Jun, and R-v-Jun-m1( ¼ R-m1) Figure 2 Nucleotide sequence (5 0 -3 0 ) of the short a2 (I) collagen promoter À433/ þ 11 covering the transcriptional start point (position þ 1) and the 11 first nucleotides of exon 1 (capitalized) (Pallante et al., 1996) . Arrowheads indicate the position of the first nucleotide present in the deleted forms used in this study. The tata box, TCC-rich region (À211/À182), AP1-like motif (À283/À289), GC box (À322/À330), and restriction sites used for cloning are underlined. Nucleotide changes introduced in some of the promoter constructs are presented underneath the sequence. À, no change. A complete sequence of the large -1080/ þ 109 promoter fragment, which includes the begining of noncoding exon 1 has been deposited in the GenBank database (Accession number AJ 630474)
Repression of a2 (I) collagen by v-Jun S Chamboredon and M Castellazzi form, À72/ þ 11, which still contains the tata box, showed a barely significant, basal activity (o5%) with no change due to v-Jun(-m1). Taken together, these transactivation data demonstrated that (i) À433/ þ 11 is the shortest fragment that retains both high basal activity and repression by v-Jun(-m1), and that (ii) À237/ þ 11 lacks a region, which contributes to the basal level of activity and is specifically required for repression by v-Jun but not v-Jun-m1. Moreover, assuming that both oncoproteins share a common mechanism of repression, these data also show that repression by vJun requires two distinct promoter regions located on each side of position À237.
Ubiquitous transcription factors Sp1 and Sp3 modulate the activity of À433/ þ 11
As already stated above, basal activity of the avian SPARC promoter and repression by v-Jun(-m1) were mediated by Sp1 and Sp3 (Chamboredon et al., 2003) . We, therefore, wanted to know whether these ubiquitous transcription factors also affected a2 (I) collagen activity. As shown in Figure 4 , this was indeed the case, in that (i) Sp1, and to a lesser extent Sp3, activated À1080/ þ 11 and À433/ þ 11, and that (ii) a dominantnegative form of Sp1, designated DNSp1, repressed these promoters significantly, with an efficiency close to v-Jun. Note that DNSp1 lacks most of the N-terminal, transactivation domain (amino acids 3-516) but still remains capable of binding to the DNA specifically (Chamboredon et al., 2003) .
Two potential Sp1/3 binding sites contribute to repression by v-Jun
Having shown that both v-Jun and Sp1/3 affect transcription of À433/ þ 11 in opposite directions, we wondered whether binding sites for these transcription factors exist in this promoter fragment. Computer analysis did not reveal any consensus Jun binding site, but a unique, AP-1-like motif 5 0 -CGAGTCA (from position À289 to À283; Figure 2 ). It is interesting to note that, in the human promoter, an identical sequence (from position À265 to À241) has been reported to bind Jun, contribute to high basal activity, and be fundamental for TGF-b response (Chung et al., 1996) . Therefore, a À433/ þ 11 derivative was constructed, designated 433/ þ 11 mAP1, in which the AP-1-like motif was replaced by 5 0 -CGCCTTG, which does not bind Jun anymore. As shown in Figure 5a , wild-type and mutated À433/ þ 11 were identically repressed by v-Jun and v-Jun-m1, demonstrating that the AP-1-like We previously reported (Chamboredon et al., 2003 ) that the minimal SPARC promoter is repressed by swapping mutants of v-Jun, which can only make homodimers (i.e. v-Jun/glz, carrying the homodimerization domain of yeast GCN4; Jurdic et al., 1995) and cannot bind AP-1 sites anymore (i.e. v-Jun/cebp/glz, carrying a DNA-binding domain of the c/EBP transcription factor; Basso et al., 2000; Ramji and Foka, 2002) . To eliminate any direct binding of the latter mutant to the collagen promoter (for instance, via the postulated CAT box at position À86/À80; Vogeli et al., 1981) , we decided to construct another v-Jun derivative, designated v-Jun/b/glz, which carries a single Alanine to Lysine substitution at position 221 in the basic domain. This mutation specifically abolishes DNA binding without affecting nuclear translocation (unpublished data; Mikaelian et al., 1993) . As shown in Figure 5b , vJun/glz and v-Jun/b/glz repressed À433/ þ 11 with an efficiency close to wild-type v-Jun, demonstrating that, as already reported for the short SPARC promoter, DNA binding (and heterodimerization) were not required for repression.
Computer analysis further revealed a consensus Sp1 site 5 0 -GGGCGGG (i.e. GC box; from position À330 to À322; Figure 2 ) and a large 5 0 -TCC-rich region (from position À211 to À182). The latter sequence is reminiscent to the 5 0 -GGA repeat which, in À124/ þ 16 SPARC, is responsible for Sp1/3 binding and repression by v-Jun. To estimate the contribution of these motifs to repression by v-Jun, À433/ þ 11 derivatives were generated, which harbor mutations in the upstream consensus site (mGC), in the TCC-rich region (mTCC), and in both sites (mGC þ mTCC). As shown in Figure 5c , each mutation affected repression, although at a different level; whereas mTCC still retained about half the repression of the wild-type promoter, mGC abolished repression totally.
Taken together, and keeping in mind that v-Jun(-m1) can physically interact with Sp1 and Sp3 in vitro (Chamboredon et al., 2003) , the transactivation data presented so far invited us to propose the working hypothesis depicted in Figure 6a (see also Discussion). In this hypothesis: (i) Sp1 and/or Sp3 bind to the DNA directly, through the GC box and the TCC-rich region; and (ii) v-Jun represses transcription by binding to the À433/ þ 11 collagen promoter indirectly, through a physical interaction with Sp1/3. The various experiments presented hereafter were designed to try to support this hypothesis.
Sp1 and Sp3, but not v-Jun(-m1), bind to the À433/ þ 11 promoter fragment in vitro Electrophoretic mobility shift assays were performed to characterize the DNA-protein complexes, which bind À433/ þ 11. In a first series of experiments, nuclear extracts from CEFs stably transformed by R-v-Jun were used with a radioactive probe À433/ þ 11. As shown in Figure 7a , a large, slow-migrating smear and several minor, low-molecular-weight bands were observed. Competition with nonradioactive, excess consensus Sp1 and Jun ( ¼ AP1) probes suggested that SP1(-like) proteins, but not Jun, were present in the smear.
To try to resolve the Sp-containing smear from Figure 7a , similar experiments with the same extracts were performed with the shorter, contiguous probes À433/À237 and À237/ þ 11. As shown in Figure 7b , probe À433/À237 gave rise to a smear, which again was competed by cold probe Sp1. It also was competed by probe GC (which includes the consensus GC box), but not probe mGC, a mutated version of probe GC, which no longer binds Sp1 in vitro. In contrast, probe À237/ þ 11 gave rise to a series of small, discrete retarded bands, noted C1-C6, according to the distance of migration (Figure 7c ). Competition by probe TCC (which covers the entire TCC-rich region) and consensus probe Sp1, In a second series of experiments, in vitro prepared avian Sp1, Sp3 and v-Jun(-m1) were tested for their ability to bind to probe À433/ þ 11. As shown in Figure  8a -d, the following results were obtained: (i) Sp1 and Sp3 bound to À433/ þ 11, À433/À237, and À237/ þ 11, as distinct retarded bands; (ii) v-Jun(-m1) did not bind to À433/ þ 11 (even in the presence of another AP1 partner such as ATF2 and Fra2 present in transformed CEFs; data not shown); moreover, no supershift due to v-Jun could be detected in the presence of Sp1, Sp3, or a mixture of these factors.
In conclusion, the data in Figures 7 and 8 are in line with the model in Figure 6a , in that (i) À433/ þ 11 binds Sp1/3 factors, and that (ii) this binding is likely to involve two separated motifs, that is, the upstream GC box and the TCC-rich region. However, in contrast to what is predicted in the model, the data do not support the presence of a Jun-containing complex in the different retarded bands.
Sp1, Sp3, and v-Jun interact with the endogenous a2 (I) collagen promoter Although electrophoretic gel shift assays did not reveal any direct evidence of the presence of v-Jun(-m1) at the level of the -433/ þ 11 promoter, we nevertheless decided to test whether the oncoprotein can bind to the promoter region indirectly, as a component of a multimeric Sp1/3-containing complex associated with chromatin. To test this hypothesis, chromatin immunoprecipitation assays (ChIP assays), using anti-Jun, antiSp1, or anti-Sp3 antibodies, were performed in normal CEFs transiently transfected by a pDP vector overexpressing v-Jun. Indeed, as shown in Figure 9a , each antibody could efficiently immunoprecipitate the proximal fragment of the endogenous promoter, whereas control preimmune serum were inefficient. As the antiJun antibody used did not discriminate between v-Jun and the endogenous c-Jun, another ChIP assay was carried out with CEF cells stably transformed by the retroviral vector R-v-Jun. It is well documented that in such transformed cells, v-Jun downregulates the endogenous c-Jun and, thus, remains the predominant, if not exclusive, Jun component present in the cells (Gao et al., 1996; Kilbey et al., 1996; Hussain et al., 1998; Vial et al., 2000b) . As shown in Figure 9b , anti-Jun precipitated the endogenous promoter efficiently, strongly suggesting that v-Jun, rather than endogenous c-Jun, was associated to the Sp1/3-DNA complex at the level of the collagen proximal promoter region.
Functional analysis of the À433/ þ 11 promoter in SL2 cells
In another attempt to test the hypothesis in Figure 6 , we decided to investigate the activity of the À433/ þ 11 promoter fragment in the Drosophila embryonic SL2 cell line (Schneider, 1972) . These cells constitute a convenient tool in such a study, in that they naturally lack homologs of mammalian transcription factors Sp1 and Sp3 (Courey and Tjian, 1988; Santoro et al., 1988) . As shown in Figure 10a , the À433/ þ 11 promoter displayed a low level of constitutive activity in these heterologous cells (as well as À72/ þ 11; presumably because of the presence of a tata box in these proximal fragments). This constitutive activity was strongly stimulated by Sp1 and Sp3, thus confirming that these factors are important for high level transcription. Transient transfections, comparing wild-type À433/ þ 11 and the mGC and mTCCderivatives, further indicated that this stimulation was largely dependent on an intact GC box and TCC-rich region (data not shown).
Importantly, v-Jun and v-Jun-m1 alone did not significantly affect promoter activity. They, however, repressed the promoter activity induced by Sp1/3 ( Figure 10a ). As deduced from the Western blot data in Figure 10c , this v-Jun-mediated repression could not be attributed to a reduced steady-state accumulation of either Sp1 or Sp3 in the transfected cells; it was also unlikely to be due to a deleterious activity of v-Jun(-m1) in an SL2 background. Indeed, to ascertain this latter point, a control transfection experiment was conducted in which v-Jun and v-Jun-m1 were shown to activate a minimal model promoter, designated 5 Â coll-tata, consisting of a tata box associated with an upstream multimerized Jun-binding consensus motif from the human collagenase promoter (van Dam et al., 1993) . This result demonstrated that these oncoproteins were transcriptionally active in SL2, and, consequently, that the absence of activation without Sp1/3 and the repression with Sp1/3 were promoter-specific phenomena.
Finally, indirect binding of v-Jun to the À433/ þ 11 promoter through Sp1 and Sp3 was tested in SL2 cells using the ChIP assay. Cotransfections of À433/ þ 11 and v-Jun were conducted in the presence or not of Sp1 or Sp3. As shown in Figure 10d , polyclonal antibodies directed against v-Jun precipitated the promoter efficiently, but only in the presence of either Sp1 or Sp3. In contrast, as expected, the same antibodies immunoprecipitated the 5 Â coll-tata promoter directly (Figure 10d , right panel). Taken together, these data clearly indicated that, at least in SL2 cells transfected with a promoter carried on a plasmid, v-Jun binds to À433/ þ 11 indirectly, most likely through the formation of a DNA-Sp1/3-v-Jun chromatin-associated complex.
Discussion
In this paper, we first confirmed that the a2 (I) collagen gene is downregulated in CEFs transformed by v-Jun, and, more efficiently, by v-Jun-m1, a highly tumorigenic, dimerization mutant of v-Jun . To get further insights into this repression mechanism, the properties of a large fragment of the collagen promoter, extending from À1080 to þ 109, were investigated. Transient transfection experiments revealed that high basal activity and v-Jun-mediated repression take place within À1080/ þ 109, and also within a shorter form À433/ þ 11. Therefore, various experiments using transient transactivations, electrophoretic mobility shift assays, and ChIP assays were conducted with wild-type À433/ þ 11 and mutated derivatives, successively in CEF cells and in Drosophila SL2 cells deficient in Sp1 and Sp3 activities. Taken together, the various results invited us to propose a This hypothesis is reminiscent of that recently postulated for repression of the SPARC target gene by v-Jun(-m1) in the same cellular model (Figure 6b ; Chamboredon et al., 2003) . Interestingly, proximal promoters of both targets possess a similar stretch of 5 0 -GGA (or 5 0 -TCC), that is, a 30-nucleotide-long 5 0 -TCC-rich region (within collagen) and a 24-nucleotide-long 5 0 -GGA region (within SPARC). These stretches constitute unusual, low-affinity binding sites for Sp1/3 (Ihn et al., 1997; Chamboredon et al., 2003) . They contribute to high basal activity and repression by v-Jun. The reason why such sequences have been selected remains unclear. In fact, their presence does not seem to be critical for the repression by v-Jun per se, for the following reasons. Firstly, in the À433/ þ 11 collagen promoter, the high-affinity GC box is abso- In each case, a 258 bp fragment containing the À237/ þ 11 fragment of the endogenous a2 (I) collagen promoter was amplified by PCR from input chromatin or from chromatin immunoprecipitated with specific antibodies. Anti-Sp/J0 and anti-Sp/J74 are polyclonal sera at day 0 of immunization (control serum) and at day 74 (immune serum) from the same rabbit, respectively. Anti-Jun/J0 and antiJun/J92 are polyclonal sera at day 0 of immunization (control serum) and at day 92 (immune serum) from the same rabbit, respectively Repression of a2 (I) collagen by v-Jun S Chamboredon and M Castellazzi lutely required for repression, whereas the proximal 5 0 -TCC only partially contribute to repression (Figure 5c ). Secondly, in the À124/ þ 16 SPARC promoter, the 5 0 -GGA region can be entirely replaced by a 24-nucleotidelong sequence containing an Sp1 consensus element and still retain repression by v-Jun (Figure 11a ; note that in this experiment, as expected, a mutated GGA motif, which cannot bind Sp1/3 anymore abolishes promoter activity totally). Thirdly, an artificial model promoter Sp1-tata, containing a single Sp1 consensus element upstream to the minimal tata box in pGL2, also displays clear repression by v-Jun (Figure 11b ). In addition to showing that the purine-rich stretches were not essential for repression, the latter experiment further suggests Repression of a2 (I) collagen by v-Jun S Chamboredon and M Castellazzi that, in v-Jun-transformed CEFs at least, a more general inhibiting effect by the oncoprotein is exerted on Sp1-controlled promoters, the Sp1 target site(s) being upstream of a tata box, as in the a2 type I collagen and the minimal model promoter, or replacing the tata box itself, as in the SPARC promoter. The absence of v-Jun-containing bands in electrophoretic mobility shift assays has been observed repeatedly in experiments with the collagen and SPARC probes (this paper; Chamboredon et al., 2003) . Such a negative result has also been reported in similar studies in human cells with c-Jun acting indirectly through Sp1, either as an activator on p21 (in hepatoma HepG2 cells; Kardassis et al., 1999) and on vimentin (in breast cancer MCF7 cells; Wu et al., 2003) , or as a repressor on p21 (in embryonic 293 cells; Wang et al., 2000) . This situation could simply reflect a high dissociation constant between v-Jun and Sp1/3. It rather invited us to postulate the existence of (an)other factor(s) not present in nuclear extracts, which assemble(s) and stabilize(s) v-Jun and Sp1/3 bound to DNA (Figures  6a and b) . In this respect, it is interesting to note that an 'assembly' factor has recently been described, which integrates activating and repressing signals at AP-1-regulated promoters through interaction with the glucocorticoid receptor bound to DNA (Kassel et al., 2004) . Therefore, an analysis of the composition of in vivo immunoprecipitated Jun-Sp1/3-containing complexes by recently available protein technologies, such as mass spectrometry followed by microsequencing, should be informative.
The highly tumorigenic mutant v-Jun-m1 functions as a more robust repressor in comparison to v-Jun. This is now well established in the case of the collagen and SPARC promoters. The reason for that, however, remains mysterious. For instance, a higher accumulation of v-Jun-m1 has not been systematically found and, therefore, cannot explain the discrepancy between the two proteins (this paper; Huguier et al., 1998; Vial and Castellazzi, 2000a; Vial et al., 2000b; Chamboredon et al., 2003) . A possible explanation might consider that Jun represses as a dimer rather than a monomer. This would be in line with the fact that v-Jun-m1 homodimers are 5-to 10-fold more stable in comparison to v-Jun homodimers, and, consequently, bind to a consensus DNA probe more efficiently (Figure 8b ; J Baguet and M Castellazzi, unpublished data). The higher stability of the v-Jun-m1 dimers might also contribute to stabilize the postulated v-Jun(-m1)-Sp1/3-DNA complex from the À433/ þ 11 collagen fragment and explain why the mutated oncoprotein represses the shorter À237/ þ 11 fragment, which lacks one of the two Sp1/3 binding sites.
In conclusion, the a2 (I) collagen is likely to constitute another example of a direct target of v-Jun which, like SPARC, is downregulated by an indirect binding of the oncoprotein to the proximal promoter through the ubiquitous Sp1/3 factors. As numerous promoters, containing or not a tata box, have been reported to be controlled by Sp1/3, more such direct targets of v-Jun might exist. The combination of ChIP assay (Weinmann et al., 2001; Weinmann and Farnham, 2002) with the use of v-Jun/b/glz unable to bind to DNA anymore (Brown et al., 1996; Kardassis et al., 1999) should facilitate the identification of such a family of direct targets.
Materials and methods

Cell culture
Primary CEFs were prepared from 8-day-old, virus-free, Oline chicken embryos (Institute for Animal Health, Compton, Berks, UK). They were grown in regular medium made of Ham's F10 medium (Eurobio) supplemented with 10% tryptose phosphate broth (Difco), 5% fetal calf serum (Eurobio) and 1% chicken serum (Sigma), 0.196% NaCO 3 , penicillin/streptomycin, and 1.25 mg/ml amphotericin B at 371C in a 5% CO 2 atmosphere (Perez et al., 2001) . v-Junexpressing cultures were obtained by chronic infection with the replication-competent retrovirus Rcas (Hugues et al., 1987) . Rcas (noted R), R-v-Jun, and R-v-Jun-m1 ( ¼ R-m1) have already been described (Vial and Castellazzi, 2000a; Vial et al., 2000b) . Drosophila SL2 cells were maintained in Schneider's insect medium (Invitrogen) supplemented with 10% fetal calf serum (Eurobio) and penicillin/streptomycin at 251C in a normal atmosphere (Schneider, 1972) .
Promoter constructs
The various collagen promoter fragments used in this study were derived from the À1064 to þ 110 fragment in plasmid pF1CAT (Pallante et al., 1996) . Several corrections and additions have been made to the published sequence (Boedtker et al., 1985) , which have resulted in changes in the nucleotide numbering. The corrected sequence, hereafter referred to as À1080/ þ 109, has been deposited into the GenBank database and given Accession number AJ630474. The various promoter fragments were cloned into pGL3 basic (Promega) in front of the luciferase reporter gene. Fragments À1080/ þ 109, À820/ þ 109, and À433/ þ 11 were recovered as StuI(blunt ended)-HindIII, EagI(blunt end)-HindIII, and XmaI-XmaI restriction fragments, and inserted into pGL3 at SmaI and HindIII, or XmaI, respectively. Fragment À237/ þ 11 was recovered as an NheI(artificial site)-XmaI PCR fragments and cloned into pGL3 at NheI and XmaI. Fragment À72/ þ 11 was derived from À433/ þ 11 pGL3 in which the 5 0 MluI-PstI promoter fragment was removed, and the integrity of the plasmid restored after end blunting and religation. mGC, mAP1, and mTCC were introduced into À433/ þ 11 using the QuikChange site-directed mutagenesis kit (Stratagene), with changes in sequence as indicated in Figure 2 . The SPARC promoter constructs À124/ þ 16 and À56/ þ 16 were described previously (Vial et al., 2000b) . Again the sitedirected mutagenesis kit was used to replace the repeat of eight GGA motifs (À87/À64) of À124/ þ 16 by a mutated GGA motif, which can no longer bind Sp1, or with a consensus Sp1 binding motif. The inserted sequences are in the sense orientation: 5 0 -ggATTAggATTAggATTAggA TTA ( ¼ mutated GGA; the gg to TT substitutions are underlined), and 5 0 -ggATTCgATCggggCggggCgAgC ( ¼ consensus Sp1, underlined), respectively.
The pGL2 derivatives carrying the minimal promoters 5 Â coll-tata and tata were described previously . The Sp1 motif was introduced into pGL2 tata-luciferase by replacing the PstI-tata-XhoI region in front of the luciferase gene by the following double-stranded oligonucleotide sequence: in the sense orientation, 5 0 -ggggggCggggCC TgggATCCAgATCTCTCTgAgCAATAgTATAAAAC; and in the antisense orientation, 5 0 -TCgAgTTTTATACTATTgC TCAgAgAgATCTggATCCCAggCCCCgCCCCCCTgCA. The Sp1 consensus site and the tata box are underlined. Modifications in the various promoters were confirmed by DNA sequencing. Recloning of the PCR-derived sequences was also performed in order to eliminate any possible mutation outside the promoter region.
v-Jun mutants
v-Jun/glz was described previously (Chamboredon et al., 2003) . v-Jun/b/glz was constructed using the site-directed mutagenesis kit (Stratagene), replacing the gCg wild-type triplet (Ala221) by the AAg sequence (Lys221) within the basic DNA-binding domain.
Transient transactivation assays
Transient transfection assays into CEFs or Drosophila SL2 cells were performed strictly as already described (Chamboredon et al., 2003) . The luciferase activities were normalized for the basal activities displayed by a2 (I) collagen À72/ þ 11, SPARC À56/ þ 16, or tata-luciferase, depending upon the experiment. In these assays, the v-Jun, v-Jun-m1 ( ¼ m1), Sp1 and Sp3 coding sequences were expressed from the Rous sarcoma virus 5 0 -LTR in a pDP plasmid (Vandel et al., 1996) in CEFs, and from the actin AC5 promoter in a pAc5.1/V5-HisA plasmid (Invitrogen) in SL2 cells.
Electrophoretic mobility shift assay
Preparation of nuclear extracts and in vitro made proteins, and gel shift assays were conducted as described previouly (Chamboredon et al., 2003) . Radioactive probes À433/ þ 11 and À237/ þ 11 were obtained after enzymatic digestion with SstI þ XhoI, dephosphorylated, purified by the Genclean kit, and 32 P-labeled with T4 kinase. Radioactive probe À433/À237 was obtained by PCR using the primer sense: 5 0 -CCCggggCgC CgCCCCAggCC and antisense: 5 0 -CggCggCgCTAAATTggT TCC, purified using the Genclean kit (Q-Biogene), and 32 P-labeled with T4 kinase.
ChIP assays
ChIP assays were performed as described already (Chamboredon et al., 2003) . Owing to the high percentage of GC in the promoter sequences, PCR reactions (35 cycles) were performed in the presence of 4% dimethylsulfoxide. To visualize the amplified products, traces of [a-32 P]dCTP were added in the PCR reactions. The PCR products were resolved on a nondenaturing, 5% polyacrylamide gel. In CEF cells, amplification of the endogenous proximal collagen promoter was carried out using the following primers: in the sense orientation, 5 0 -ggAACCAATTTAgCgCTgCCg; and in the antisense orientation, 5 0 -gAACCTgCTgCCCgggATgCTA. To amplify the transfected collagen promoter sequences in SL2 cells, the same sense primer was used, but the antisense primer was located in the luciferase gene of pGL3, that is, 5 0 -CAgTTgCTCTCCAgCggTTCCATC. The amount of input DNA was estimated by amplifying an aliquot representing 0.4 or 4% of the sonicated samples before immunoprecipitation of the endogenous or transfected promoter fragment, respectively.
Northern blotting
Total RNA extraction and Northern blot analysis were performed as published (Vial and Castellazzi, 2000a) . Radioactives probes were coding sequences of avian a2 (I) collagen, SPARC, and GAPDH. Abbreviations CEF(s), chicken embryo fibroblast(s); SPARC, secreted protein, acidic, and rich in cysteine; AP1, activating protein 1; ChIP assay, chromatin immunoprecipitation assay.
